EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $344,000 | -52.7% | 101,118 | +2.1% | 0.00% | -33.3% |
Q2 2023 | $728,000 | -28.3% | 99,038 | +1.1% | 0.00% | -25.0% |
Q1 2023 | $1,015,000 | -11.7% | 97,943 | +0.6% | 0.00% | -20.0% |
Q4 2022 | $1,150,000 | -17.3% | 97,405 | +47.0% | 0.01% | -16.7% |
Q3 2022 | $1,391,000 | -31.7% | 66,275 | +1.0% | 0.01% | -33.3% |
Q2 2022 | $2,036,000 | +18.6% | 65,590 | +56.9% | 0.01% | +50.0% |
Q1 2022 | $1,716,000 | +3137.7% | 41,798 | +3357.2% | 0.01% | – |
Q4 2021 | $53,000 | -97.1% | 1,209 | -96.7% | 0.00% | -100.0% |
Q3 2021 | $1,840,000 | -20.0% | 36,742 | +0.6% | 0.01% | -12.5% |
Q2 2021 | $2,301,000 | -37.7% | 36,529 | -8.1% | 0.01% | -46.7% |
Q1 2021 | $3,693,000 | +2.0% | 39,751 | -1.7% | 0.02% | -6.2% |
Q4 2020 | $3,622,000 | -15.0% | 40,420 | -2.0% | 0.02% | -30.4% |
Q3 2020 | $4,261,000 | +4.4% | 41,238 | -20.1% | 0.02% | 0.0% |
Q2 2020 | $4,082,000 | +15.3% | 51,621 | -15.6% | 0.02% | -4.2% |
Q1 2020 | $3,539,000 | +41.7% | 61,169 | +32.2% | 0.02% | +84.6% |
Q4 2019 | $2,497,000 | +3.7% | 46,281 | +0.5% | 0.01% | 0.0% |
Q3 2019 | $2,407,000 | +21.9% | 46,049 | +12.6% | 0.01% | +18.2% |
Q2 2019 | $1,975,000 | -45.8% | 40,889 | -43.3% | 0.01% | -42.1% |
Q1 2019 | $3,644,000 | +11.5% | 72,123 | +30.8% | 0.02% | 0.0% |
Q4 2018 | $3,268,000 | +55.6% | 55,127 | +72.8% | 0.02% | +90.0% |
Q3 2018 | $2,100,000 | +24.6% | 31,898 | -4.5% | 0.01% | +11.1% |
Q2 2018 | $1,686,000 | -6.5% | 33,398 | -2.5% | 0.01% | 0.0% |
Q1 2018 | $1,804,000 | +7.8% | 34,265 | -4.9% | 0.01% | +12.5% |
Q4 2017 | $1,674,000 | +11.5% | 36,023 | -3.0% | 0.01% | 0.0% |
Q3 2017 | $1,502,000 | -39.9% | 37,135 | -49.6% | 0.01% | +14.3% |
Q2 2017 | $2,500,000 | +139.5% | 73,732 | +105.1% | 0.01% | +16.7% |
Q1 2017 | $1,044,000 | +5.7% | 35,949 | +8.8% | 0.01% | 0.0% |
Q4 2016 | $988,000 | +0.2% | 33,029 | +5.6% | 0.01% | 0.0% |
Q3 2016 | $986,000 | +94.9% | 31,282 | +73.7% | 0.01% | +100.0% |
Q2 2016 | $506,000 | -22.7% | 18,009 | 0.0% | 0.00% | -25.0% |
Q1 2016 | $655,000 | -9.2% | 18,009 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $721,000 | +40.5% | 18,009 | 0.0% | 0.00% | +33.3% |
Q3 2015 | $513,000 | – | 18,009 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |